Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO-Reference-Cited by-同舟云学术

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

Published:2020-03 Issue:3 Volume:31 Page:334-351
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Chen L.-T.,Martinelli E.,Cheng A.-L.,Pentheroudakis G.,Qin S.,Bhattacharyya G.S.,Ikeda M.,Lim H.-Y.,Ho G.F.,Choo S.P.,Ren Z.,Malhotra H.,Ueno M.,Ryoo B.-Y.,Kiang T.C.,Tai D.,Vogel A.,Cervantes A.,Lu S.-N.,Yen C.-J.,Huang Y.-H.,Chen S.-C.,Hsu C.,Shen Y.-C.,Tabernero J.,Yen Y.,Hsu C.-H.,Yoshino T.,Douillard J.-Y.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference123 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. The global epidemiology of hepatocellular carcinoma: present and future;McGlynn;Clin Liver Dis,2011

3. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Vogel;Ann Oncol,2018

4. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma;Chen;Hepatology,1991

5. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study;Koh;Br J Cancer,2011

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic arterial-infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma;2024-09-09

2. Current Trends in Hepatocellular Carcinoma Therapies in China;Digestive Disease Interventions;2024-08-26

3. The current status and future of targeted-immune combination for hepatocellular carcinoma;Frontiers in Immunology;2024-08-05

4. Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis;Frontiers in Pharmacology;2024-07-31

5. Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment;Journal of Gastrointestinal Cancer;2024-07-12